EPCAM and ovarian carcinoma: A number of DARPin molecules that specifically bind to different tumor-associated antigens, such as human epidermal growth factor receptor 2 (HER2) or the epithelial cell adhesion molecule (EpCAM) overexpressed in breast and ovarian cancer cells, have been developed [8,9,10,11,12].